AbCellera Biologics Inc. ABCL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$43.17M-383% | -$8.95M+84.3% | -$57.12M-64.5% | -$34.73M+23.9% | -$45.62M-33.4% | ||
| $5.92M+14.2% | $5.18M+20.5% | $4.3M-4.4% | $4.5M+2.1% | $4.41M+110% | ||
| $12.01M-6.9% | $12.9M-7.1% | $13.9M-2.2% | $14.21M-3.9% | $14.79M-2.9% | ||
| -$9.41M-264% | $5.74M+13.3% | $5.07M+228% | -$3.95M-15.8% | -$3.41M-152% | ||
| $1.74M+157% | -$3.07M-389% | -$628K+89.8% | -$6.13M+16.3% | -$7.32M-48.0% | ||
| -$2.38M-155% | $4.32M+361% | -$1.66M-157% | $2.88M+230% | -$2.21M— | ||
| -$8.03M-78.1% | -$4.51M— | —— | —— | $13.31M— | ||
| -$4.97M+50.6% | -$10.05M+17.6% | -$12.2M-284% | -$3.18M+27.9% | -$4.41M-129% | ||
| $920K— | —— | $940K+1.2% | $929K+0.8% | $922K— | ||
| $1.82M+1.1% | $1.8M-9.7% | $1.99M+25.2% | $1.59M+24.7% | $1.27M-4.6% | ||
| -$13.1M-133% | $39.67M+1,055% | $3.43M-69.9% | $11.39M+905% | $1.13M-94.6% | ||
| —— | $7.53M0.0% | $7.53M0.0% | $7.53M0.0% | $7.53M— | ||
| -$33.52M+3.5% | -$34.74M+33.9% | -$52.59M-62.3% | -$32.4M-180% | -$11.55M-44.4% | ||
| $3.83M-61.1% | $9.84M+10.2% | $8.93M-33.2% | $13.37M+25.7% | $10.64M-32.0% | ||
| —— | -$8.32M0.0% | -$8.32M0.0% | -$8.32M0.0% | -$8.32M— | ||
| -$25.08M-133% | $75.14M+106% | $36.49M+215% | -$31.81M-501% | $7.94M-77.8% | ||
| $7.19M+74.8% | $4.12M-44.2% | $7.37M— | —— | $5.97M+44.1% | ||
| -$38K-113% | $290K— | —— | $761K+29.0% | $590K+127% | ||
| -$51.45M— | —— | -$9.28M+86.1% | -$66.83M-2,372% | $2.94M-90.1% | ||
| $920K+1.2% | $909K-3.3% | $940K+1.2% | $929K+0.8% | $922K— | ||
| $5.92M+14.2% | $5.18M+20.5% | $4.3M-4.4% | $4.5M+2.1% | $4.41M+110% | ||
| —— | $7.53M0.0% | $7.53M0.0% | $7.53M0.0% | $7.53M— | ||
| —— | -$1.13M0.0% | -$1.13M0.0% | -$1.13M0.0% | -$1.13M-107% | ||
| $2.36M+193% | $804K-30.3% | $1.15M+150% | $461K-62.2% | $1.22M+137% | ||
| -$8.03M-78.1% | -$4.51M— | —— | —— | $13.31M— | ||
| $1.74M+157% | -$3.07M-389% | -$628K+89.8% | -$6.13M+16.3% | -$7.32M-48.0% | ||
| $1.82M+1.1% | $1.8M-9.7% | $1.99M+25.2% | $1.59M+24.7% | $1.27M-4.6% | ||
| -$2.38M-155% | $4.32M+361% | -$1.66M-157% | $2.88M+230% | -$2.21M— | ||
| —— | -$8.32M0.0% | -$8.32M0.0% | -$8.32M0.0% | -$8.32M— | ||
| $105K-67.4% | $322K-89.2% | $2.99M-52.6% | $6.3M-15.8% | $7.48M— | ||
| $1.36M-90.3% | $13.98M+1,423% | $918K-83.1% | $5.43M+433% | $1.02M-84.5% | ||
| —— | $7.43M0.0% | $7.43M0.0% | $7.43M0.0% | $7.43M+120% | ||
| $7.19M— | —— | $7.55M+32.9% | $5.68M-4.8% | $5.97M— | ||
| -$37.35M+16.2% | -$44.59M+27.5% | -$61.52M-34.4% | -$45.77M-106% | -$22.19M+6.1% | ||
| -$37.35M+16.2% | -$44.59M+27.5% | -$61.52M-34.4% | -$45.77M-106% | -$22.19M+6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s cash flow data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.